Quantum Biopharma Ltd. Files May 2025 6-K Report
Ticker: QNTM · Form: 6-K · Filed: May 28, 2025 · CIK: 1771885
| Field | Detail |
|---|---|
| Company | Quantum Biopharma Ltd. (QNTM) |
| Form Type | 6-K |
| Filed Date | May 28, 2025 |
| Risk Level | low |
| Sentiment | neutral |
Sentiment: neutral
Topics: 6-K, foreign-private-issuer, disclosure
TL;DR
Quantum Biopharma (fka FSD Pharma) filed its May 6-K, standard foreign private issuer report.
AI Summary
Quantum Biopharma Ltd. (formerly FSD Pharma Inc. as of March 27, 2019) filed a Form 6-K on May 28, 2025. The filing is a Report of Foreign Private Issuer for the month of May 2025. The company is incorporated in A6 and its fiscal year ends on December 31. Its principal executive office is located at 55 University Ave., Suite 1003, Toronto, Ontario M5J2H7, Canada.
Why It Matters
This filing provides routine disclosure for Quantum Biopharma Ltd. as a foreign private issuer, updating the SEC on its status for the month of May 2025.
Risk Assessment
Risk Level: low — This filing is a routine report and does not contain new material financial information or significant operational updates.
Key Players & Entities
- Quantum Biopharma Ltd. (company) — Filer
- FSD Pharma Inc. (company) — Former company name
- 20190327 (date) — Date of name change
- May 2025 (date) — Reporting period
- 20250528 (date) — Filing date
- 001-39152 (other) — SEC File Number
FAQ
What is the purpose of this Form 6-K filing?
This Form 6-K is a Report of Foreign Private Issuer filed pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934, for the month of May 2025.
What was Quantum Biopharma Ltd.'s former name?
Quantum Biopharma Ltd.'s former name was FSD Pharma Inc., with a date of name change on March 27, 2019.
Where is Quantum Biopharma Ltd.'s principal executive office located?
The company's principal executive office is located at 55 University Ave., Suite 1003, Toronto, Ontario M5J2H7, Canada.
Does Quantum Biopharma Ltd. file under Form 20-F or Form 40-F?
Quantum Biopharma Ltd. indicates it files annual reports under cover of Form 20-F.
What is the SIC code for Quantum Biopharma Ltd.?
The Standard Industrial Classification (SIC) code for Quantum Biopharma Ltd. is 2834, Pharmaceutical Preparations.
Filing Details
This Form 6-K (Form 6-K) was filed with the SEC on May 28, 2025 regarding Quantum Biopharma Ltd. (QNTM).